CoChat

Synthesis of bioengineered heparin chemically and biologically similar to porcine-derived products and convertible to low MW heparin

Open access

The DOI matches its Crossref record; 67 of the 69 references it cites were found in a registry or an index.

Abstract

Heparins have been invaluable therapeutic anticoagulant polysaccharides for over a century, whether used as unfractionated heparin or as low molecular weight heparin (LMWH) derivatives. However, heparin production by extraction from animal tissues presents multiple challenges, including the risk of adulteration, contamination, prion and viral impurities, limited supply, insecure supply chain, and significant batch-to-batch variability. The use of animal-derived heparin also raises ethical and religious concerns, as well as carries the risk of transmitting zoonotic diseases. Chemoenzymatic synthesis of animal-free heparin products would offer several advantages, including reliable and scalable production processes, improved purity and consistency, and the ability to produce heparin polysaccharides with molecular weight, structural, and functional properties equivalent to those of the United States Pharmacopeia (USP) heparin, currently only sourced from porcine intestinal mucosa. We report a scalable process for the production of bioengineered heparin that is biologically and compositionally similar to USP heparin. This process relies on enzymes from the heparin biosynthetic pathway, immobilized on an inert support and requires a tailored N -sulfoheparosan with N -sulfo levels similar to those of porcine heparins. We also report the conversion of our bioengineered heparin into a LMWH that is biologically and compositionally similar to USP enoxaparin. Ultimately, we demonstrate major advances to a process to provide a potential clinical and sustainable alternative to porcine-derived heparin products.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.2315586121

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1. Time courses of multi-gram synthetic reactions leading to a 10 g BEH batch. (A and B) Time course of two sequential sub-batches of the C5-epi/2OST reactions (#1 and #2), with magnification (B) to visualize 2S, IdoA, and GlcA2S disaccharides. (C) Time course of two sequential sub-batches of the 6OST-1/6OST-3 reactions (#1 and #2). (D) Time course of the single batch 3OST-1 reaction. Curves fitted using two-phase association model.
Fig. 1. Time courses of multi-gram synthetic reactions leading to a 10 g BEH batch. (A and B) Time course of two sequential sub-batches of the C5-epi/2OST reactions (#1 and #2), with magnification (B) to visualize 2S, IdoA, and GlcA2S disaccharides. (C) Time course of two sequential sub-batches of the 6OST-1/6OST-3 reactions (#1 and #2). (D) Time course of the single batch 3OST-1 reaction. Curves fitted using two-phase association model.CC BY-NC-ND · PubMed Central
Fig. 2. Characterization of BEH. (A) Di- and tetrasaccharide composition of final, desalted BEH compared to USP heparin (mean ± SD, USP-H n = 32, BEH 0.5 g n = 3, BEH 10 g n = 1). (B) 1D and 2D NMR analysis of USP heparin vs. BEH. BEH (10 g batch) and USP heparin samples were dissolved in 2H2O and lyophilized repeatedly to achieve full deuterium exchange. The samples were then analyzed by 1D 1H and 2D 1H/13C HSQC NMR on 600 MHz spectrometer. Acquisition parameters and peak assignments were set according to Mauri et al. (50, 61). (C) 1D 1H-NMR analysis of LMWHs, enoxaparin sodium. Samples were dissolved in 2H2O and lyophilized repeatedly to achieve full deuterium exchange and analyzed by 1D 1 H NMR on 600 MHz spectrometer. LMWH products were prepared using current depolymerization process from Celsus USP UFH (purple) and BEH UFH (green). Commercially available samples (controls) were a generic enoxaparin sodium (red) and Lovenox® (blue).
Fig. 2. Characterization of BEH. (A) Di- and tetrasaccharide composition of final, desalted BEH compared to USP heparin (mean ± SD, USP-H n = 32, BEH 0.5 g n = 3, BEH 10 g n = 1). (B) 1D and 2D NMR analysis of USP heparin vs. BEH. BEH (10 g batch) and USP heparin samples were dissolved in 2H2O and lyophilized repeatedly to achieve full deuterium exchange. The samples were then analyzed by 1D 1H and 2D 1H/13C HSQC NMR on 600 MHz spectrometer. Acquisition parameters and peak assignments were set according to Mauri et al. (50, 61). (C) 1D 1H-NMR analysis of LMWHs, enoxaparin sodium. Samples were dissolved in 2H2O and lyophilized repeatedly to achieve full deuterium exchange and analyzed by 1D 1 H NMR on 600 MHz spectrometer. LMWH products were prepared using current depolymerization process from Celsus USP UFH (purple) and BEH UFH (green). Commercially available samples (controls) were a generic enoxaparin sodium (red) and Lovenox® (blue).CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 67 references

Research works printed but not linked: 1

  1. 10.1160/th11-07-0518 · doi:10.1160/th11-07-0518

Cited by

See all 37

Metadata

Authors
Douaisi, M., Paskaleva, E. E., Fu, L., Grover, N., McManaman, C. L., Varghese, S., Brodfuehrer, P. R., Gibson, J. M., de Joode, I., Xia, K., Brier, M. I., Simmons, T. J., Datta, P., Zhang, F., Onishi, A., Hirakane, M., Mori, D., Linhardt, R. J., & Dordick, J. S.
Affiliations
  • Rensselaer Polytechnic Institute (US)
  • Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, NY 12180
Corresponding author
  • Linhardt, Robert J.
  • Dordick, Jonathan S.
Venue
Proceedings of the National Academy of Sciences
Published
2024-03-18
Volume
121
Issue
14
Pages
e2315586121-e2315586121
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W4392931669
Cited by
31
References
69
Citations by year
2026: 13 · 2025: 13 · 2024: 5
FWCI
6.97
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
Heparin Applied Research Center (NA)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
  • Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Polysaccharides Composition and Applications
Keywords
heparin, low molecular weight heparin, enoxaparin, chemoenzymatic synthesis, immobilized enzymes
MeSH terms
Animals, Anticoagulants, Drug Contamination, Heparin, Heparin, Low-Molecular-Weight, Molecular Weight, Swine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Synthesis of bioengineered heparin chemically and biologically similar to porcine-derived products and convertible to low MW heparin. https://app.cochat.ai/papers/10.1073/pnas.2315586121
The paper
Douaisi, M., Paskaleva, E. E., Fu, L., Grover, N., McManaman, C. L., Varghese, S., Brodfuehrer, P. R., Gibson, J. M., de Joode, I., Xia, K., Brier, M. I., Simmons, T. J., Datta, P., Zhang, F., Onishi, A., Hirakane, M., Mori, D., Linhardt, R. J., & Dordick, J. S. (2024). Synthesis of bioengineered heparin chemically and biologically similar to porcine-derived products and convertible to low MW heparin. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2315586121

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.